INVESTOR’S REPORT · 1/10/2021  · CEL-SCI Corporation (CVM), founded in 1983, is a biotech...

21

Transcript of INVESTOR’S REPORT · 1/10/2021  · CEL-SCI Corporation (CVM), founded in 1983, is a biotech...

Page 1: INVESTOR’S REPORT · 1/10/2021  · CEL-SCI Corporation (CVM), founded in 1983, is a biotech company that tests, researches, and develops cancer drugs, as well as autoimmune and
Page 2: INVESTOR’S REPORT · 1/10/2021  · CEL-SCI Corporation (CVM), founded in 1983, is a biotech company that tests, researches, and develops cancer drugs, as well as autoimmune and

INVESTOR’S REPORT

1

10 STOCKS WITH THE POWER TO

DOUBLE YOUR MONEY – TIME AND TIME AGAIN

There are 5,000 stocks in the U.S. stock market. So finding the right stock for you can be difficult – but there’s no need to worry or spend all day trying to pinpoint what you need – because that’s where my Super Options system comes in.

When it comes to trading, I like to keep things simple. And that’s exactly why over the last few years, I have honed in on 112 big names in the market. These 112 stocks make up the top 2% of the entire market. And they have consistently delivered massive wins to Super Options members.

You see, when I built my Super Options system, I wanted to make a powerful, easy-to-follow trading tool. And that’s why using this system, I have pinpointed 10 out of the 112 stocks that consistently perform well for us.

These 10 stocks have proven to be the best of the best when it comes to our Super Options style of trading. In fact, these 10 stocks are a class all on their own. No other stock can touch what they bring to the table.

And after months of profiting off these big names and gathering some in-depth research – I’m finally ready to reveal everything I know about these major profit players.

Now, I call these 10 stocks the Super Options Frequent Flyers, and in my eyes, they truly are the “all stars” of Super Options.

Page 3: INVESTOR’S REPORT · 1/10/2021  · CEL-SCI Corporation (CVM), founded in 1983, is a biotech company that tests, researches, and develops cancer drugs, as well as autoimmune and

INVESTOR’S REPORT

2

And right now, I’m going to give you the full scoop on all 10 Super Options Frequent Flyers. You’re going to learn their history, what sector they serve, and why these almost always seem to bring home the big bucks.

In this report, you’ll get:

1. The snapshot of the company’s entire stock performance…

2. The lowdown of the company – what they do and the customers they serve, and…

3. The shakeup– why the profit potential of these companies stands out above competitors.

So let’s get started.

Page 4: INVESTOR’S REPORT · 1/10/2021  · CEL-SCI Corporation (CVM), founded in 1983, is a biotech company that tests, researches, and develops cancer drugs, as well as autoimmune and

INVESTOR’S REPORT

3

FREQUENT FLYER #1: VICR

Snapshot:

Lowdown:

Based in Massachusetts, Vicor Corporation (VICR) designs and manufactures electrical power converters both in the U.S. and abroad. Incorporated in 1981, this company has prospered for the past four decades. And as you can see by the snapshot above, the pandemic shutdown has been an absolute godsend for the company’s stock.

Not to mention, Vicor is a manufacturing powerhouse with 15 subsidiaries all over the world, including France, Italy, the UK, Hong Kong, Japan, and China. Last year, it had a revenue of $262.98M.

Shakeup:

As we see successful coronavirus vaccines prepare to enter the market, VICR is a stock that should benefit from the good news. They’re expected to double earnings over the next few years. And the stock has gone from $30 to $90 over the past few months.

100%

80%

60%

40%

20%

0%

1994 2002 2010 2018

VICOR CORP. (VICR)

Page 5: INVESTOR’S REPORT · 1/10/2021  · CEL-SCI Corporation (CVM), founded in 1983, is a biotech company that tests, researches, and develops cancer drugs, as well as autoimmune and

INVESTOR’S REPORT

4

I’m especially interested to see a pullback in this price range because the general wisdom says that a stock that hit $80 usually goes to $120. And when we see the pullback, S.C.A.N. will send us a signal immediately. So keep your eyes open for my alert.

Page 6: INVESTOR’S REPORT · 1/10/2021  · CEL-SCI Corporation (CVM), founded in 1983, is a biotech company that tests, researches, and develops cancer drugs, as well as autoimmune and

INVESTOR’S REPORT

5

FREQUENT FLYER #2: CVM

Snapshot:

Lowdown:

CEL-SCI Corporation (CVM), founded in 1983, is a biotech company that tests, researches, and develops cancer drugs, as well as autoimmune and infectious disease treatments. The company’s stock performance may appear abysmal, but it’s not because of sales. In 1992, the SEC issued a cease and desist order against the company’s president at the time because he was late to file over 16 forms documenting the company’s sales. But don’t let this drop deceive you, analysts have been saying CVM is an undervalued stock ever since 1996.

Shakeup:

Right now, CVM is about to disrupt the entire biotech industry. This past February, the company was issued a trading halt on its shares for news pending. This is because their main product, Multikine, is currently undergoing Phase III clinical trials with the FDA. Now, biotech stocks are always tricky because one FDA trial could send the stock soaring to the sky or dropping to the ground.

$20K

$15K

$10K

$5K

$0

1988 1998 2008 2018

CEL. SCI CORP. (CVM)

Page 7: INVESTOR’S REPORT · 1/10/2021  · CEL-SCI Corporation (CVM), founded in 1983, is a biotech company that tests, researches, and develops cancer drugs, as well as autoimmune and

INVESTOR’S REPORT

6

That’s why CVM is the perfect options play. With S.C.A.N., we make money no matter which way the stock moves. And in light of their FDA trials, I can easily picture big, fast gains after they announce the latest results.

Page 8: INVESTOR’S REPORT · 1/10/2021  · CEL-SCI Corporation (CVM), founded in 1983, is a biotech company that tests, researches, and develops cancer drugs, as well as autoimmune and

INVESTOR’S REPORT

7

FREQUENT FLYER #3: SHAK

Snapshot:

Lowdown:

Have you ever tasted the wonder of a Shake Shack burger? Shake Shack Inc. (SHAK) started out in 2001 as a hot dog cart inside Madison Square Park. Over the past 19 years, it’s become one of the most popular national burger chains in America. The company IPO’ed on January 29, 2015, and saw an immediate 123% rise in stocks. And with over 250 locations all across the planet, the sky is the limit for this delicious hamburger restaurant.

Shakeup:

After suffering a slight setback, SHAK stock has been powering through the pandemic shutdown as if nothing happened. The company fully embraced the online-delivery revolution, and combined with their takeout service, Shake Shack’s stock is on track to blow past its all-time high. After a 52-week low of $30, the stock rocketed up to $90. This is a stock we’ve made money on before, and it’s only a matter of time before S.C.A.N. gives us another SHAK trade to make even more money on.

$100

$80

$60

$40

$20

2016 2017 2018 2019 2020

SHAKE SHACK INC. (SHAK)

Page 9: INVESTOR’S REPORT · 1/10/2021  · CEL-SCI Corporation (CVM), founded in 1983, is a biotech company that tests, researches, and develops cancer drugs, as well as autoimmune and

INVESTOR’S REPORT

8

FREQUENT FLYER #4: YETI

Snapshot:

Lowdown:

Founded in 2006, YETI Holdings Inc. (YETI) is barely 14 years old. Yet this new company has established itself as the preeminent brand of its sector. They’re pretty much the “iPod” of the cooler industry. Their products include mugs, bottles, and coolers, and they specialize in vacuum-insulated ice chests and other related accessories.

YETI is the top-of-the-line brand in the outdoor manufacturing space, and their products aren’t cheap. Their mugs cost around $30, and their ice chests are also pricier than their competitors’ products. But just like the iPod, YETI customers are brand-loyal patrons who have shown that they will always remain on team YETI.

Shakeup:

YETI is one of my favorite low-float names. The stock has been consistently breaking its personal records ever since the pandemic started, and it actually reached its all-time high during the economic shutdown. People are rediscovering a passion for the

$60

$50

$40

$30

$20

$10

2020

YETI HOLDINGS INC. (YETI)

Page 10: INVESTOR’S REPORT · 1/10/2021  · CEL-SCI Corporation (CVM), founded in 1983, is a biotech company that tests, researches, and develops cancer drugs, as well as autoimmune and

INVESTOR’S REPORT

9

outdoors (or rediscovering a passion for cold beers on Sunday), and YETI has become a symbol of high-quality outdoor gear. YETI’s superior technology, combined with their superior marketing, has allowed them to quickly establish themselves as the bona fide leader of their sector.

Page 11: INVESTOR’S REPORT · 1/10/2021  · CEL-SCI Corporation (CVM), founded in 1983, is a biotech company that tests, researches, and develops cancer drugs, as well as autoimmune and

INVESTOR’S REPORT

10

FREQUENT FLYER #5: RPD

Snapshot:

Lowdown:

Cybersecurity is currently one of the hottest sectors on the market, and Rapid7 Inc. (RPD) is one of the leaders in this fast-growing industry. Founded in 2000, the company has been around for the past two decades. They went public in July 2015, and the stock started gaining extreme upward momentum in 2018.

Shakeup:

There are very few stocks that have the sheer upside potential that RPD has. Not only do they lead their industry but RPD is a low-float stock with a market cap of just $3.6 billion. Which means there’s an extremely good chance that they will get bought out by a larger institution.

When the economy was first shut down, RPD stock dropped along with the rest of the market. But since then, the company’s stock has hit new all-time highs over and over again. And I don’t see this trend stopping anytime soon.

$80

$60

$40

$20

$0

2017 2018 2019 2020

RAPID7 INC. (RPD)

Page 12: INVESTOR’S REPORT · 1/10/2021  · CEL-SCI Corporation (CVM), founded in 1983, is a biotech company that tests, researches, and develops cancer drugs, as well as autoimmune and

INVESTOR’S REPORT

11

FREQUENT FLYER #6: PETS

Snapshot:

Lowdown:

Founded in 1996, PetMed Express Inc. (PETS) is the parent company of 1-800-PetMeds and operates a pet pharmacy in the United States. You’ve probably heard on the news that millennials spend more money on their pets than any other generation, and this company’s performance shows it.

Organic pet food, cute dog costumes, and silk collars aside… millennials are also forking over cash for their pets’ prescription drugs. If this pandemic has proven anything, it’s that people will continue to spend money on their “fur babies.” It doesn’t matter if the market is moving up, down, left, or right… if Fido needs medicine, he’s going to get it.

Shakeup:

Currently, the stock is in between its all-time high of $40 and its 52-week low of $21. Combined with their low float, PETS is looking ready to pop back up to its all-time-high levels. And with the American public growing more comfortable ordering

$60

$40

$20

$0

2001 2007 2013 2019

PETMED EXPRESS INC. (PETS)

Page 13: INVESTOR’S REPORT · 1/10/2021  · CEL-SCI Corporation (CVM), founded in 1983, is a biotech company that tests, researches, and develops cancer drugs, as well as autoimmune and

INVESTOR’S REPORT

12

things online, sales and revenue should remain consistent for the foreseeable future. In fact, sales and revenue should dramatically increase because of this prolonged pandemic shutdown. People are discouraged from going to the store, and many will order online for the first time and realize shopping for pet meds online is too convenient to ever visit the store again.

Page 14: INVESTOR’S REPORT · 1/10/2021  · CEL-SCI Corporation (CVM), founded in 1983, is a biotech company that tests, researches, and develops cancer drugs, as well as autoimmune and

INVESTOR’S REPORT

13

FREQUENT FLYER #7: PFSI

Snapshot:

Lowdown:

Founded in 2008, PennyMac Financial Services Inc. (PFSI) is one of America’s top mortgage banking companies. They’ve serviced $388 billion in loans. They have over 1.8 million happy homeowners. And they continue to dominate their industry. They’re also the number-one issuer of government loans, like Federal Housing Administration and Veterans Affairs mortgage products. The government loan sector is an especially profitable sector since the loans are underwritten by the U.S. government.

Born during the heyday of the 2008 financial crisis, PFSI is one of the few mortgage companies that prospered and maintained a stellar reputation.

Shakeup:

PFSI is an industry leader in multiple sectors, and COVID-19 has launched the stock into the stratosphere. We continue to see U.S. home sales grow stronger, which suggests even greater profits for PennyMac.

$80

$60

$40

$20

$0

2015 2016 2017 2018 2019 2020

PENNYMAC FINANCIAL SERVICES INC. (PFSI)

Page 15: INVESTOR’S REPORT · 1/10/2021  · CEL-SCI Corporation (CVM), founded in 1983, is a biotech company that tests, researches, and develops cancer drugs, as well as autoimmune and

INVESTOR’S REPORT

14

What’s more, the Fed has declared they will continue to lower interest rates, which means now is a great time to trade this low-float stock. Many first-time homebuyers are jumping on a mortgage to take advantage of the low interest rates, and I’m fully expecting a huge pop that will shatter all-time highs any day now. And when S.C.A.N. gives us that signal, you and I will be the first people to know that PFSI is a big buy.

Page 16: INVESTOR’S REPORT · 1/10/2021  · CEL-SCI Corporation (CVM), founded in 1983, is a biotech company that tests, researches, and develops cancer drugs, as well as autoimmune and

INVESTOR’S REPORT

15

FREQUENT FLYER #8: EBIX

Snapshot:

Lowdown:

Ebix Inc. (EBIX) is a software company that was founded in 1976. They provide e-commerce services to insurance, financial, health care, and e-learning industries all across the planet. I can’t think of a better business to invest your money in right now.

EBIX reported revenues of $141.6 million in Q1 2020. And their Q3 2020 revenues were $154.3 million. Which means they made even more money thanks to the pandemic.

Shakeup:

This stock is in the right place, and it’s the right time to buy. After nearing its 52-week low of $8 due to the pandemic, EBIX has been steadily climbing back up. Not to mention, EBIX is always on my radar. The low price point and steady price patterns have made it one of our most profitable Super Options Frequent Flyers.

$100

$80

$60

$40

$20

$0

1992 1997 2002 2007 2012 2017

EBIX INC. (EBIX)

Page 17: INVESTOR’S REPORT · 1/10/2021  · CEL-SCI Corporation (CVM), founded in 1983, is a biotech company that tests, researches, and develops cancer drugs, as well as autoimmune and

INVESTOR’S REPORT

16

FREQUENT FLYER #9: VUZI

Snapshot:

Lowdown:

Vuzix Corporation (VUZI) was founded in 1997, and they manufacture, market, and sell augmented reality (AR) wearable displays and computing devices. Intel also owns 30% of this company. Basically, these guys make those funky virtual reality headsets that cover your eyes. VUZI stock has a great track record with Super Options, which is why this stock is always on my radar.

Shakeup:

The gaming industry is abuzz with two new entertainment systems coming out (a new PlayStation and a new Xbox). And VUZI is positioned at the right place and the right time to profit immensely from the next generation of video games. People aren’t leaving their houses and are discovering new sources of entertainment. With a new gaming console, you can bet they’ll be virtual reality compatible. And VUZI’s wearable displays will be just one of the many accessories people will be buying.

As the virtual reality industry continues to mature rapidly, I expect VUZI to be the big dog of the sector. With IBM’s 30% stake in

$15

$10

$5

$0

2012 2014 2016 2018 2020

VUZI CORP. (VUZI)

Page 18: INVESTOR’S REPORT · 1/10/2021  · CEL-SCI Corporation (CVM), founded in 1983, is a biotech company that tests, researches, and develops cancer drugs, as well as autoimmune and

INVESTOR’S REPORT

17

the company, VUZI has the backing of a 109-year-old American technology juggernaut.

With a 52-week low of $0.80 and an all-time high of $8, VUZI is a cost-effective profit play that’s sure to line our pockets once again.

Page 19: INVESTOR’S REPORT · 1/10/2021  · CEL-SCI Corporation (CVM), founded in 1983, is a biotech company that tests, researches, and develops cancer drugs, as well as autoimmune and

INVESTOR’S REPORT

18

FREQUENT FLYER #10: JWN

Snapshot:

Lowdown:

Nordstrom Inc. (JWN) is one of the retail names that always adapts. Back in 2008, the stock was decimated but bounced back to all-time highs. We’re currently seeing a similar situation with JWN stocks taking a beating due to COVID-19, but the company is as strong as ever. And I fully expect stock prices to rally once again towards new all-time highs, just like it did following the 2008 crisis.

Shakeup:

It’s undeniable that sales and profits plunged for Nordstrom, but the numbers don’t tell the full story. With the entire economy shut down for most of the spring and summer, it’s natural to have fewer sales. Yet the company generated $187 million in cash from Q1 2020. They easily made positive cash flow and used that money to pay down their revolving credit line borrowings.

Not to mention, their online sales are surging to new heights, and with a possible vaccine around the corner, all factors suggest that

$80

$60

$40

$20

$0

1986 1996 2006 2016

NORDSTROM INC. (JWN)

Page 20: INVESTOR’S REPORT · 1/10/2021  · CEL-SCI Corporation (CVM), founded in 1983, is a biotech company that tests, researches, and develops cancer drugs, as well as autoimmune and

INVESTOR’S REPORT

19

Nordstrom’s stock will soar right back to pre-pandemic levels.

And these 10 stocks are just the beginning of the profit potential I’m showing my Super Options readers. Check it out…

AFTER STUNNING BETA TEST RESULTS, WE’RE OFFICIALLY PULLING BACK THE CURTAIN

For the last three months, a group of handpicked subscribers has been testing out a new options trading technique for fast, explosive gain potential.

The results have been astonishing.

Some of our best plays have more than DOUBLED folks’ accounts in just one day. Others banked 400%+ gains in 24 hours.

And today, we’re officially opening the floodgates for the first time. Tune in here.

Page 21: INVESTOR’S REPORT · 1/10/2021  · CEL-SCI Corporation (CVM), founded in 1983, is a biotech company that tests, researches, and develops cancer drugs, as well as autoimmune and

Copyright 2007-present, Money Map Press, 1125 N. Charles Street, Baltimore, MD 21201 Phone: 888.384.8339 or 443.353.4519

All rights reserved. Money Map Press provides its members with unique opportunities to build and protect wealth, globally, under all market conditions. The executive staff, research department and edi-tors who contribute to Money Map Press recommendations are proud of our history and reputation. We believe the advice presented to our subscribers in our published resources and at our meetings and seminars is the best and most useful available to global investors today. The recommendations and analysis presented to members is for the exclusive use of members. Copying or disseminating any infor-mation published by Money Map Press, electronic or otherwise, is strictly prohibited. Members should be aware that investment markets have inherent risks and there can be no guarantee of future profits. Likewise, past performance does not assure future results. Recommendations are subject to change at any time, so members are encouraged to make regular use of the website and pay special attention to Money Map Press updates sent out via e-mail. The publishers, editors, employees or agents are not responsible for errors and/or omissions.

PRIVACY NOTICE

You and your family are entitled to review and act on any recommendations made in this document. All Money Map Press publications are protected by copyright. No part of this report may be reproduced by any means (including facsimile) or placed on any electronic medium without written permission from the publisher. Information contained herein is obtained from sources believed to be reliable, but its accuracy cannot be guaranteed. Money Map Press expressly forbids its writers from having a financial interest in any security recommended to its readers. All Money Map Press employees and agents must wait 24 hours after an Internet publication and 72 hours after a print publication is mailed prior to following an initial recommendation. Money Map Press does not act as a personal investment advisor, nor does it advocate the purchase or sale of any security or investment for any specific individual. Investments recommended in this publication should be made only after consulting with your investment advisor, and only after re-viewing the prospectus or financial statements of the company.

Money Map Press is not a broker, dealer or licensed investment advisor. No person listed here should be considered as permitted to engage in rendering personalized investment, legal or other professional advice as an agent of Money Map Press. Money Map Press does not receive any compensation for these services. Additionally, any individual services rendered to subscribers by those mentioned are considered completely separate from and outside the scope of services offered by Money Map Press. Therefore if you choose to contact anyone listed here, such contact, as well as any resulting relationship, is strictly between you and them.

WEBSOP-0121-1897

PLEASE NOTE

From time to time, Money Map Press will recommend stocks or other investments that will not be included in our regular portfolios. There are certain situations where we feel a company may be an extraordinary value but may not necessarily fit within the selection guidelines of these existing portfolios. In these cases, the recommendations are speculative and should not be considered as part of Money Map Press philosophy.

Also, by the time you receive this report, there is a chance that we may have exited a recommendation previ-ously included in our portfolio. Occasionally, this happens because we use a disciplined selling strategy with our investments, meaning that if a company’s share price falls below a certain price level, we immediately notify our subscribers to sell the stock.